Variable | aged 65 years or below (Group A) (N = 45) | early-stage elderly individuals (Group B) (N = 52) | late-stage elderly individuals aged 75 years or over (Group C) (N = 53) | |
Number of cases | 45 | 52 | 53 | |
Age | 57.2 ± 5.2 | 69.2 ± 2.9 | 81.6 ± 4.3 | |
Gender (Female %) | 21.10% | 28.10% | 50.90% | |
Disease duration (year) | 5.8 ± 4.8** | 8.4 ± 5.1 | 10.5 ± 6.3** | AC** |
Body mass index (kg/m2≤) BMI | 26.2 ± 4.7 | 24.4 ± 3.2 | 23.4 ± 3.9** | C** |
blood pressure: SBP (mmHg) | 137 ± 17 | 136 ± 16 | 143 ± 19 | |
blood pressure: DBP (mmHg) | 80 ± 11 | 73 ± 13 | 70 ± 12** | C** |
Number of antihypertensive agents | 1.9 ± 0.9 | 2.2 ± 1.2 | 2 ± 1.0 | |
T-Cho (mg/dl) | 189.5 ± 37.3 | 184.2 ± 33.7 | 182.1 ± 40 | |
TG (mg/dl) | 167.9 ± 89 | 157.1 ± 83 | 135 ± 69 | |
HDL-C (mg/dl) | 49 ± 11.6 | 48.9 ± 15 | 52.4 ± 13.7 | |
LDL-C (mg/dl) | 98.1 ± 25 | 94 ± 25.4 | 97.2 ± 29.9 | |
BUN (mg/dl) | 14.5 ± 3.5 | 16.7 ± 5.0 | 16.7 ± 4.6 | |
CRE (mg/dl) | 3.2 ± 1.0 | 0.84 ± 0.2 | 0.83 ± 0.26 | |
UA (mg/dl) | 5.8 ± 1.4 | 5.6 ± 1.4 | 5.4 ± 1.0 | |
Glucose (mg/dl) | 117.7 ± 36 | 126.8 ± 43 | 113.8 ± 26.2 | |
HbA1c (%) | 6.26 ± 1.0 | 6.15 ± 0.82 | 6.2 ± 0.76 | |
Cardiothoracic ratio: CTR (%) | 49 ± 5.4 | 50.5 ± 4.9 | 52 ± 6.5 | |
Left ventricular ejection fraction: EF (%) | 62 ± 13 | 66 ± 4.7 | 65 ± 4.1 | |
Ankle Brachial Index (Rt): ABI (Rt) | 1.2 ± 0..1 | 1.1 ± 0.8 | 1.1 ± 0.13 | |
Ankle Brachial Index (Lt): ABI (Lt) | 1.19 ± 0.09 | 1.18 ± 0.07 | 1.12 ± 0.1 | |
Pulse Wave Velocity (Rt): PWV (Rt) | 1554.3 ± 240 | 1776 ± 500 | 2012 ± 325 | |
Pulse Wave Velocity (Lt): PWV (Lt) | 1550 ± 256.5 | 1849.2 ± 573.4 | 2037.5 ± 327.7 |